project id: TCGA-HNSC; case submitter id: TCGA-DQ-7595; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 9.1; age at index: 53; days to birth: -19530; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 19530; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic n: NX; ajcc pathologic t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1190.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 4.383561643835616; pack years smoked: 80.0; is ffpe: false; weight: 25.0; composition: Not Reported; days to collection: 499; days to sample procurement: 0; intermediate dimension: 0.2; longest dimension: 0.3; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-DQ-7595-01A-11; percent lymphocyte infiltration: 10.0; percent necrosis: 0.0; percent normal cells: 25.0; percent stromal cells: 25.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0;